Sartorius Stedim Biotech Acquires BioOutsource

News
Article

The acquisition expands Sartorius Stedim Biotech’s service portfolio.

 

Sartorius Stedim Biotech (SSB), a supplier for the biopharmaceutical industries, has acquired BioOutsource, a CRO based in Glasgow, United Kingdom. This move expands SSB’s portfolio with the addition of contract testing services to support biopharmaceutical clients and help fast-track biologics through the development pipeline as well as facilitate lot release testing in large-scale manufacturing.

BioOutsource recorded EUR9 million in revenue over the past 12 months. The privately owned Scottish company, which employs approximately 85 staff, has been operating in the biotech space since 2007. It provides contract testing services to the biopharmaceutical industry, including assays to monitor the safety and quality of biologic products. BioOutsource’s services are used in early stage drug development for characterization, comparability, and lot release testing of biotherapeutics.

Details of the transaction were not disclosed.

Source: Sartorius Stedim Biotech

 

 

Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis to Expand US-Based R&D and Manufacturing

Susan Haigney
April 11th 2025
Article

The company has plans to invest $23 billion during the next five years to expand manufacturing and R&D in the US, which will include seven new facilities.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Microsoft and SkyCell Collaborate on Pharma Supply Chain Logistics

Susan Haigney
April 9th 2025
Article

SkyCell is working with Microsoft to incorporate SkyCell’s AI-powered supply chain solution into Microsoft Teams and Copilot.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Nano particle molecule. Nano medicine and nanotechnology biotechnology concept. Organic or inorganic polymeric sphere, capsule, quantum. | Image Credit: ©Irina - stock.adobe.com

Enhancing Solubility and Bioavailability with Nanotechnology

Cynthia A. Challener
April 7th 2025
Article

Advanced solutions are improving drug dissolution, absorption, and overall therapeutic performance.

Electronic three dimensional plastic printer during work | Image Credit: © andrew_shots - stock.adobe.com

Entering New Domains for 3D Printing of Drug Products

Anna Kirstine Jørgensen;Alvaro Goyanes;Abdul W. Basit
April 6th 2025
Article

3D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.